Literature DB >> 23111829

Characterization of NCI-H295R cells as an in vitro model of hyperaldosteronism.

U D Lichtenauer1, I Shapiro, A Osswald, S Meurer, A Kulle, M Reincke, F Riepe, F Beuschlein.   

Abstract

In depth analysis of key molecular mechanisms involved in functional autonomy of aldosterone secretion is hampered by the lack of tumor cell lines that reflect functional characteristics of aldosterone producing adenomas. Herein, we describe the characteristics of the adrenocortical carcinoma cell line NCI-H295R and its suitability as a model of hyperaldosteronism in relation to different culture conditions. Steroid profiling revealed that NCI-H295R cells predominantly secrete cortisol, while aldosterone and other steroids are released at much lower concentrations. However, aldosterone output specifically increased in response to different stimuli such as ACTH and angiotensin II, and in particular to potassium in a dose dependent manner. NCI-H295R cells readily formed spheroids under specific culture conditions, a method widely used for the enrichment of progenitor cells. Unexpectedly, spheroid cells excelled with higher aldosterone concentration and higher expression levels of the steroidogenic enzymes StAR, 3βHSD, CYP17, SF-1, and the MC2-receptor. Further investigations revealed that this phenomenon is mainly attributed to epithelial growth factor (EGF) and particularly fibroblast growth factor (FGF), which are both essential ingredients in the spheroid culture medium. Aldosterone release under the combinatory influence of EGF and FGF was not higher than the effect of FGF alone. Spheroid growth per se, therefore, does not ensure an enrichment of less differentiated cell types in this cell line. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23111829     DOI: 10.1055/s-0032-1323810

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  9 in total

1.  MiR-193a-3p functions as a tumour suppressor in human aldosterone-producing adrenocortical adenoma by down-regulating CYP11B2.

Authors:  Guoxi Zhang; Xiaofeng Zou; Quanliang Liu; Tianpeng Xie; Ruohui Huang; Huan Kang; Changfu Lai; Jiaxing Zhu
Journal:  Int J Exp Pathol       Date:  2018-04-17       Impact factor: 1.925

2.  Hepatocyte Growth Factor/cMET Pathway Activation Enhances Cancer Hallmarks in Adrenocortical Carcinoma.

Authors:  Liem M Phan; Enrique Fuentes-Mattei; Weixin Wu; Guermarie Velazquez-Torres; Kanishka Sircar; Christopher G Wood; Tao Hai; Camilo Jimenez; Gilbert J Cote; Levent Ozsari; Marie-Claude Hofmann; Siyuan Zheng; Roeland Verhaak; Lance Pagliaro; Maria Angelica Cortez; Mong-Hong Lee; Sai-Ching J Yeung; Mouhammed Amir Habra
Journal:  Cancer Res       Date:  2015-08-17       Impact factor: 12.701

3.  The PI3K/AKT/mTOR signaling pathway is overactivated in primary aldosteronism.

Authors:  Hengchuan Su; Yanyun Gu; Fengying Li; Qidi Wang; Baoxing Huang; Xiaolong Jin; Guang Ning; Fukang Sun
Journal:  PLoS One       Date:  2013-04-23       Impact factor: 3.240

4.  Single-cell molecular profiling of all three components of the HPA axis reveals adrenal ABCB1 as a regulator of stress adaptation.

Authors:  Juan Pablo Lopez; Elena Brivio; Alice Santambrogio; Carlo De Donno; Aron Kos; Miriam Peters; Nicolas Rost; Darina Czamara; Tanja M Brückl; Simone Roeh; Max L Pöhlmann; Clara Engelhardt; Andrea Ressle; Rainer Stoffel; Alina Tontsch; Javier M Villamizar; Martin Reincke; Anna Riester; Silviu Sbiera; Martin Fassnacht; Helen S Mayberg; W Edward Craighead; Boadie W Dunlop; Charles B Nemeroff; Mathias V Schmidt; Elisabeth B Binder; Fabian J Theis; Felix Beuschlein; Cynthia L Andoniadou; Alon Chen
Journal:  Sci Adv       Date:  2021-01-27       Impact factor: 14.136

5.  The influence of TNF-α on the expression profile of key enzymes of steroidogenesis in H295R cells.

Authors:  Beniamin Grabarek; Krzysztof Cholewa; Jolanta Lodowska
Journal:  Postepy Dermatol Alergol       Date:  2021-07-26       Impact factor: 1.837

6.  Innovative multidimensional models in a high-throughput-format for different cell types of endocrine origin.

Authors:  Stefan Bornstein; Igor Shapiro; Maria Malyukov; Richard Züllig; Edlira Luca; Evgeny Gelfgat; Felix Beuschlein; Svenja Nölting; Alfredo Berruti; Sandra Sigala; Mirko Peitzsch; Charlotte Steenblock; Barbara Ludwig; Patrick Kugelmeier; Constanze Hantel
Journal:  Cell Death Dis       Date:  2022-07-25       Impact factor: 9.685

7.  Effects of Sorafenib, a Tyrosin Kinase Inhibitor, on Adrenocortical Cancer.

Authors:  Lidia Cerquetti; Barbara Bucci; Salvatore Raffa; Donatella Amendola; Roberta Maggio; Pina Lardo; Elisa Petrangeli; Maria Rosaria Torrisi; Vincenzo Toscano; Giuseppe Pugliese; Antonio Stigliano
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-24       Impact factor: 5.555

8.  Three Dimensional Cell Culturing for Modeling Adrenal and Pituitary Tumors.

Authors:  Lilla Krokker; Borbála Szabó; Kinga Németh; Rebeka Tóháti; Balázs Sarkadi; Katalin Mészáros; Attila Patócs; Henriett Butz
Journal:  Pathol Oncol Res       Date:  2021-04-21       Impact factor: 3.201

9.  Interaction between Angiotensin II and Insulin/IGF-1 Exerted a Synergistic Stimulatory Effect on ERK1/2 Activation in Adrenocortical Carcinoma H295R Cells.

Authors:  An-Li Tong; Fen Wang; Yun-Ying Cui; Chun-Yan Li; Yu-Xiu Li
Journal:  Int J Endocrinol       Date:  2016-05-12       Impact factor: 3.257

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.